|
21 CFR Part 820.250
AIHA-LAP Policies 2018 2A.7.7.1.3
ASTM E1578-18 E-10-2
EPA 815-R-05-004 Chap. IV, Sec. 7.2.8
EPA 815-R-05-004 Chap. VI, Sec. 7.8
E.U. Commission Reg. No. 2073/2005 Article 9
FDA Hazard Analysis Critical Control Point Principle 4
|
18.2 The system should allow authorized users to choose specific sample types, tests, and parameters associated with the statistical trending and control charts that can be generated.
|